Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work?
Institute of Pediatrics, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica Sacro Cuore, Rome, Italy. drigante@gmail.com.
Donato
D
Rigante
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000068800:Etanercept / Q000627:therapeutic use*; D005334:Fever / Q000188:drug therapy*; D056660:Hereditary Autoinflammatory Diseases / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept